Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02572986 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies
A Phase 3 study of Scabies, sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 3
- Development phase
- 250
- Enrollment target
- 13
- Study locations
NCT02572986 is a Phase 3 study of Scabies that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 250 participants. The trial reports 13 study locations across 8 states.
The verdict
NCT02572986, a Phase 3 study of Scabies, has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 250 participants
- Enrollment target
- 13
- Study locations
Study Summary
Scabies is an infestation of the skin by the human itch mite (Sarcoptes scabiei). Diagnosis of scabies is made based on clinical symptoms, such as nocturnal itching, and appearance and distribution of the rash. Definitive diagnosis includes the microscopic identification of the mite, mite eggs, or mite fecal matter in the skin. Topical permethrin is considered the drug of choice for the treatment of scabies. It is a synthetic pyrethroid that is safe for use in adults and children 2 months and older. This study will evaluate the therapeutic equivalence of a generic permethrin cream 5% to Elimite® in the Treatment of Scabies.
Conditions Studied
Interventions
- DRUG Permethrin
Study Locations (13)
Florida
- Solutions Through Advanced Research - Jacksonville
- San Marcus Research Clinic, Incorporation - Miami
- L & C Professional Medical Research Institute - Miami
- Vista Health Research, LLC - Miami
California
- Sun Rise Clinical Research, Inc - Bell Gardens
- Havana Research Institute - Pasadena
Other
- Clinica Dermatologica - San Salvador
- Clinica Dermatologica y Cirugia de Piel - Santa Tecla, La Libertad
Arizona
- Omni Dermatology - Phoenix
Pennsylvania
- Derm Dx Center for Dermatology - Hazleton
Texas
- Sun Research Institute - San Antonio
Washington
- Zain Research, LLC - Richland
PanamaCity
- Clinica Dermatologica Dra. Yariela Grajales - Panama City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02572986
The ClinicalTrials.gov registry entry for NCT02572986 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dr. Reddy's Laboratories Limited, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Scabies appearing as the primary indexed condition, and to 1 intervention - of which Permethrin is the first listed.
NCT02572986 reports 13 study locations spanning 8 distinct geographic areas - top geographies include Florida, California, Other.
Frequently Asked Questions
What is clinical trial NCT02572986 about?
NCT02572986 is a clinical study titled "A Study to Evaluate the Therapeutic Equivalence of Generic Permethrin Cream 5% to Elimite® in the Treatment of Scabies". Scabies is an infestation of the skin by the human itch mite (Sarcoptes scabiei). Diagnosis of scabies is made based on clinical symptoms, such as nocturnal itching, and appearance and distribution of the rash. Definitive diagnosis includes the microscopic identification of the mite, mite eggs, or m...
What is the current status of trial NCT02572986?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 2015-09. Estimated completion is 2016-08.
What conditions does trial NCT02572986 study?
This clinical trial studies the following conditions: Scabies.
What interventions are being tested in trial NCT02572986?
The interventions under investigation include: Permethrin (DRUG).
Who is sponsoring clinical trial NCT02572986?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02572986 being conducted?
This trial has 13 study locations across Arizona, California, Florida, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Scabies
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies
COMPLETED · Phase 3
-
PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.